| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/15/2023 | -28.57% | Barclays | → $4 | Initiates Coverage On | → Underweight |
| 10/05/2023 | 7.14% | BTIG | → $6 | Upgrades | Neutral → Buy |
| 10/03/2023 | -1.79% | Goldman Sachs | $6.5 → $5.5 | Maintains | Neutral |
| 08/30/2023 | 7.14% | UBS | $4.5 → $6 | Maintains | Neutral |
| 08/10/2023 | 7.14% | Morgan Stanley | $5 → $6 | Maintains | Equal-Weight |
| 08/10/2023 | 20.54% | Goldman Sachs | $6 → $6.75 | Maintains | Neutral |
| 08/10/2023 | 16.07% | Wedbush | $5 → $6.5 | Maintains | Neutral |
| 08/08/2023 | — | JMP Securities | Downgrades | Market Outperform → Market Perform | |
| 05/26/2023 | 25% | Jefferies | $5.5 → $7 | Upgrades | Hold → Buy |
| 05/12/2023 | -28.57% | Credit Suisse | $3.5 → $4 | Maintains | Underperform |
| 05/11/2023 | -19.64% | Goldman Sachs | $3.75 → $4.5 | Maintains | Neutral |
| 05/11/2023 | -10.71% | Morgan Stanley | $3.5 → $5 | Maintains | Equal-Weight |
| 05/11/2023 | -28.57% | Barclays | $3.5 → $4 | Maintains | Underweight |
| 04/28/2023 | 16.07% | JMP Securities | $5.5 → $6.5 | Maintains | Outperform |
| 03/02/2023 | -33.04% | Goldman Sachs | $3.3 → $3.75 | Maintains | Neutral |
| 03/02/2023 | -37.5% | Credit Suisse | → $3.5 | Reiterates | → Underperform |
| 03/02/2023 | -1.79% | JMP Securities | $5 → $5.5 | Maintains | Market Outperform |
| 03/02/2023 | -28.57% | Keefe, Bruyette & Woods | $3.5 → $4 | Upgrades | Underperform → Market Perform |
| 01/09/2023 | -46.43% | Barclays | $2.5 → $3 | Maintains | Underweight |
| 01/06/2023 | -55.36% | Barclays | → $2.5 | Downgrades | Equal-Weight → Underweight |
| 12/15/2022 | -37.5% | Keefe, Bruyette & Woods | → $3.5 | Downgrades | Market Perform → Underperform |
| 10/17/2022 | -55.36% | Barclays | $4 → $2.5 | Maintains | Equal-Weight |
| 10/04/2022 | -46.43% | Goldman Sachs | $3.5 → $3 | Maintains | Neutral |
| 09/30/2022 | -55.36% | Piper Sandler | $3 → $2.5 | Maintains | Underweight |
| 08/10/2022 | -37.5% | Credit Suisse | $3.75 → $3.5 | Downgrades | Neutral → Underperform |
| 07/11/2022 | -28.57% | Barclays | $5 → $4 | Maintains | Equal-Weight |
| 06/02/2022 | — | Argus Research | Downgrades | Buy → Hold | |
| 05/26/2022 | -10.71% | JMP Securities | $6 → $5 | Maintains | Market Outperform |
| 05/19/2022 | -46.43% | Piper Sandler | $5 → $3 | Downgrades | Neutral → Underweight |
| 05/17/2022 | — | Wedbush | Downgrades | Outperform → Neutral | |
| 05/12/2022 | -26.79% | Goldman Sachs | $4.6 → $4.1 | Maintains | Neutral |
| 05/11/2022 | -37.5% | Morgan Stanley | $4.5 → $3.5 | Maintains | Equal-Weight |
| 04/21/2022 | — | BTIG | Initiates Coverage On | → Neutral | |
| 04/04/2022 | -17.86% | Goldman Sachs | $5.25 → $4.6 | Maintains | Neutral |
| 03/03/2022 | -10.71% | Barclays | $7 → $5 | Maintains | Equal-Weight |
| 02/23/2022 | -10.71% | UBS | → $5 | Downgrades | Buy → Neutral |
| 01/10/2022 | 25% | Barclays | $9 → $7 | Downgrades | Overweight → Equal-Weight |
| 12/16/2021 | 42.86% | Wedbush | $8.75 → $8 | Upgrades | Neutral → Outperform |
| 12/15/2021 | 16.07% | Piper Sandler | → $6.5 | Initiates Coverage On | → Neutral |
| 10/15/2021 | 51.79% | UBS | → $8.5 | Initiates Coverage On | → Buy |
| 08/17/2021 | 33.93% | Morgan Stanley | $8 → $7.5 | Maintains | Equal-Weight |
| 07/12/2021 | 42.86% | Morgan Stanley | → $8 | Initiates Coverage On | → Equal-Weight |
| 07/09/2021 | 60.71% | Barclays | $8 → $9 | Maintains | Overweight |
| 07/02/2021 | 51.79% | Keefe, Bruyette & Woods | → $8.5 | Initiates Coverage On | → Market Perform |
| 06/23/2021 | 69.64% | Jefferies | → $9.5 | Initiates Coverage On | → Hold |
| 06/14/2021 | 78.57% | Wedbush | $9.25 → $10 | Downgrades | Outperform → Neutral |
| 06/02/2021 | 51.79% | Credit Suisse | $8 → $8.5 | Downgrades | Outperform → Neutral |
| 05/27/2021 | 78.57% | Argus Research | → $10 | Initiates Coverage On | → Buy |
| 04/21/2021 | 78.57% | Barclays | → $10 | Initiates Coverage On | → Overweight |
| 02/23/2021 | 87.5% | Credit Suisse | → $10.5 | Initiates Coverage On | → Outperform |
| 02/16/2021 | 114.29% | Deutsche Bank | → $12 | Initiates Coverage On | → Buy |
What is the target price for UWM Hldgs (UWMC)?
The latest price target for UWM Hldgs (NYSE: UWMC) was reported by Barclays on November 15, 2023. The analyst firm set a price target for $4.00 expecting UWMC to fall to within 12 months (a possible -28.57% downside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for UWM Hldgs (UWMC)?
The latest analyst rating for UWM Hldgs (NYSE: UWMC) was provided by Barclays, and UWM Hldgs initiated their underweight rating.
When is the next analyst rating going to be posted or updated for UWM Hldgs (UWMC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of UWM Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for UWM Hldgs was filed on November 15, 2023 so you should expect the next rating to be made available sometime around November 15, 2024.
Is the Analyst Rating UWM Hldgs (UWMC) correct?
While ratings are subjective and will change, the latest UWM Hldgs (UWMC) rating was a initiated with a price target of $0.00 to $4.00. The current price UWM Hldgs (UWMC) is trading at is $5.60, which is out of the analyst's predicted range.